Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polymyxin B PK/PD and dose optimization in critically ill patients
ChiCTR1900022231Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polymyxin B in Gram-negative bacterial infection, sponsored by The Second Xiangya Hospital. Primary endpoints: Blood concentration and Blood. Started Apr 2019; status: recruiting.
02
Drugs
polymyxin B
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR1900022231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022231.